Cargando…

Direct Hyperbilirubinemia as a Predictor of Mortality in Patients with Liver Cirrhosis

Detalles Bibliográficos
Autores principales:	Lee, Chang Hun, Kim, In Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283295/ https://www.ncbi.nlm.nih.gov/pubmed/34261817 http://dx.doi.org/10.5009/gnl210296

Ejemplares similares

A case report of glecaprevir/pibrentasvir-induced severe hyperbilirubinemia in a patient with compensated liver cirrhosis
por: Yoon, Jae Hyun, et al.
Publicado: (2019)

Hyperbilirubinemia and Hyponatremia as Predictors of Complicated Appendicitis
por: Shuaib, Abdullah, et al.
Publicado: (2022)

Predictors of Three-month Hospital Readmissions and Mortality in Patients with Cirrhosis of Liver
por: Lavekar, Anurag, et al.
Publicado: (2019)

Management of chronic liver diseases and cirrhosis: current status and future directions
por: Xu, Jing-Hang, et al.
Publicado: (2020)

Hyperbilirubinemia as a Risk Factor for Mortality and Morbidity in Trauma Patients
por: Lee, Mina, et al.
Publicado: (2023)

Hyperbilirubinemia as a predictor of severity of acute appendicitis
por: Akai, Masaaki, et al.
Publicado: (2019)

COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes
por: Said, Zeinab Nabil Ahmed, et al.
Publicado: (2023)

Sarcopenia as a prognostic indicator of liver cirrhosis
por: Kim, Sung‐Eun, et al.
Publicado: (2021)

Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
por: Chun, Ho Soo, et al.
Publicado: (2021)

Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
por: Lee, Chang Hun, et al.
Publicado: (2021)

The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis
por: Kang, Seong Hee, et al.
Publicado: (2018)

Patent ductus venosus in an infant with direct hyperbilirubinemia
por: Kamali, Leila, et al.
Publicado: (2019)

Hawkinsinuria With Direct Hyperbilirubinemia in Egyptian-Lebanese Boy
por: El Khatib, Hassan, et al.
Publicado: (2019)

Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis
por: Paternostro, Rafael, et al.
Publicado: (2018)

Prognostic implications of trunk muscle mass in liver cirrhosis
por: Han, Jimin, et al.
Publicado: (2018)

Diagnostic and Prognostic Markers in Liver Cirrhosis
por: Augustin, Salvador, et al.
Publicado: (2011)

Prognostic Assessment and Management of Liver Cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2017)

A need for patient-centered care in managing patients with liver cirrhosis
por: Yoon, Eileen L.
Publicado: (2021)

Liver cirrhosis and sarcopenia: a dreadful combination
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2022)

Hyperbilirubinemia as a predictor of gangrenous/perforated appendicitis: a prospective study
por: Chaudhary, Poras, et al.
Publicado: (2013)

Regression of liver cirrhosis: Orthodoxy or paradigm shift?
por: Yu, Su Jong
Publicado: (2015)

Critical issues in the diagnosis and treatment of liver cirrhosis
por: Wang, Xing, et al.
Publicado: (2019)

Neonatal hyperbilirubinemia
por: Ben, Matteo Dal, et al.
Publicado: (2014)

Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
por: Oh, Sooyeon, et al.
Publicado: (2020)

Alarming rate of 30-day hospital readmissions in patients with liver cirrhosis
por: Ebhohon, Ebehiwele, et al.
Publicado: (2021)

Radiocontrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease
por: Jo, Sang-Kyung
Publicado: (2012)

Sarcopenia is the independent predictor of mortality in critically ill patients with cirrhosis
por: Khan, Saniya, et al.
Publicado: (2022)

Liver Elastography as a Predictor of Esophageal Varices in Patients With Cirrhosis
por: Danish, Muhammad, et al.
Publicado: (2021)

Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis
por: Oh, Hyunwoo, et al.
Publicado: (2020)

Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease
por: Haydek, John Paul, et al.
Publicado: (2019)

Predictors of liver failure in primary biliary cirrhosis
por: Zhao, Pan, et al.
Publicado: (2015)

Mortality of hepatoma and cirrhosis of liver in Taiwan.
por: Lin, T. M., et al.
Publicado: (1986)

NASH‐related cirrhosis: An occult liver disease burden
por: Arrese, Marco, et al.
Publicado: (2017)

Controversies in the Management of Portal Vein Thrombosis in Liver Cirrhosis
por: Mancuso, Andrea
Publicado: (2020)

Acute Kidney Injury in Patients with Liver Cirrhosis: Prevalence, Predictors, and In-Hospital Mortality at a District Hospital in Ghana
por: Duah, Amoako, et al.
Publicado: (2022)

Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis
por: Zhang, Yue, et al.
Publicado: (2021)

The Prevalence and Predictors of Restless Legs Syndrome in Patients with Liver Cirrhosis
por: Plotogea, Oana-Mihaela, et al.
Publicado: (2022)

3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy
por: Lee, Chang Hun, et al.
Publicado: (2017)

Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis
por: Darrat, Yousef H, et al.
Publicado: (2020)

A Novel Drug with Potential to Treat Hyperbilirubinemia and Prevent Liver Damage Induced by Hyperbilirubinemia: Carbon Dots Derived from Platycodon grandiflorum
por: Chen, Rui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sv9v3am9bk1jm106kfoelrukh1